Jefferies Lifts PT on Lantheus Holdings (LNTH) to $110 From $105 – Here’s Why

Lantheus Holdings, Inc. (NASDAQ:LNTH) is one of the best high growth healthcare stocks to buy now. On March 17, Jefferies lifted the price target on Lantheus Holdings, Inc. (NASDAQ:LNTH) to $110 from $105, reaffirming a Buy rating on the shares. The firm stated that after comments at a recent conference and a meeting with the company, it is updating its prostate-specific membrane antigen positron emission tomography, or PSMA PET, model and Lantheus Holdings, Inc.’s (NASDAQ:LNTH) pricing assumptions. Jefferies further stated that it now models PSMA PET market volume growth of roughly 20% in 2025 and 10%-11% in 2026, and PYLARIFY TruVu commercial rollout in 4Q26, with meaningful contribution in 2027 and beyond.

Lantheus Holdings, Inc. (LNTH): Among Stocks with Consistent Growth to Buy Now

The rating update came the same day Lantheus Holdings, Inc. (NASDAQ:LNTH) announced that the U.S. Food and Drug Administration extended its review of the New Drug Application for LNTH-2501 (Gallium 68 edotreotide) by three months to June 29, 2026, with the extension not related to the efficacy or safety data of LNTH-2501.

Lantheus Holdings, Inc. (NASDAQ:LNTH) provides diagnostic imaging and nuclear medicine products, developing products that support healthcare professionals in patient management and outcomes and help clinicians detect cardiovascular disease. The company’s operations are divided into the U.S. and International geographical segments.

While we acknowledge the risk and potential of LNTH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than LNTH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.